'Legislative risk' on drug prices is greater now, Citi says By: CNBC.com News March 29, 2017 at 12:58 PM EDT Drugmakers may soon face renewed pressure on high prices, now that Republicans have pulled their American Health Care Act, Citi says. Read More >> Related Stocks: Astrazeneca Plc ADR Bristol-Myers Squibb CVS Health Corp Eli Lilly Express Scripts Holding Gsk Plc ADR Nasdaq Biotechnology Ishares ETF